P
P. M. Schaffer
Researcher at Ludwig Maximilian University of Munich
Publications - 35
Citations - 1168
P. M. Schaffer is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Radiosensitizer & Photodynamic therapy. The author has an hindex of 17, co-authored 35 publications receiving 983 citations. Previous affiliations of P. M. Schaffer include University of Oradea.
Papers
More filters
Journal ArticleDOI
Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.
TL;DR: Today's treatments cannot cure GBM patients but only extend their overall survival, and the use of chemoradiation, immunotherapy, and radio sensitizers as an adjuvant therapy cannot reduce the high rates of recurrence within a few months after treatment.
Journal ArticleDOI
Effects on the mitosis of normal and tumor cells induced by light treatment of different wavelengths
Ronald Sroka,Moshe Schaffer,Claudia Fuchs,Thomas Pongratz,Uta Schrader‐Reichard,Martin Busch,P. M. Schaffer,Eckhart Dühmke,Reinhold Baumgartner +8 more
TL;DR: Cell experiments were performed in order to contribute to the understanding of such a phototherapeutic procedure by means of low level energy and power.
Journal ArticleDOI
Effects of 780 nm diode laser irradiation on blood microcirculation: preliminary findings on time-dependent T1-weighted contrast-enhanced magnetic resonance imaging (MRI).
Moshe Schaffer,Harald M. Bonel,Ronald Sroka,P. M. Schaffer,Martin Busch,Maximilian F. Reiser,Eckhart Dühmke +6 more
TL;DR: It can be observed that, after biomodulation with light of low energy and low power, wound healing improves and pain is reduced, and the use of this kind of laser treatment might improve the outcome of other therapeutic modalities such as tumour ionizing radiation therapy and local chemotherapy.
Journal ArticleDOI
Curcuma as a functional food in the control of cancer and inflammation
TL;DR: This review concentrates on recent knowledge and research with curcumin clinical applications, and clinical studies, focusing on studies published between 2008 and 2011 demonstrating the gap between preclinical and clinical research.
Journal ArticleDOI
Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model.
Moshe Schaffer,P. M. Schaffer,Luigi Corti,M. Gardiman,Guido Sotti,Alfons Hofstetter,Giulio Jori,Eckhart Dühmke +7 more
TL;DR: The results of this study showed that Photofrin, a porphyrin derivative which is presently used as a tumor-photosensitizing agent in photodynamic therapy (PDT), can also act as an efficient tumor radiosensitizer.